Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48.73% | -27.69% | 693,312.15 | 0.68% | 2.63% |
|
NYSE:MRK
Merck
|
131.19 | -10.02% | 3.18% | 332,278.86 | 2.35% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
121.10 | 18.89% | 41.61% | 187,733.46 | 2.01% | 15.98% |
|
NYSE:PFE
Pfizer
|
28.64 | 8.42% | 38.65% | 162,291.22 | 5.87% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
89.17 | 19.33% | 38.3% | 111,472.92 | 4.22% | 8.19% |
|
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20,200.62 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64.8% | 124.4% | 131,830.48 | 0% | 22.71% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.29 | -46.21% | -42.74% | 18,450.72 | 0% | -2.6% |
|
NasdaqGS:VTRS
Viatris Inc
|
10.98 | 5.13% | 15.66% | 13,324.53 | 4.37% | -8.55% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18.28% | 30.99% | 10,363.08 | 2.34% | 10.99% |
|
NasdaqGS:ITCI
Intra-Cellular Therapies
|
65.00 | 0% | 0% | 6,858.14 | 0% | 0% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
600.00 | 0% | 0% | 38,517.01 | 0% | 0% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25.31% | 38.17% | 4,424.39 | 2.86% | 10.04% |
|
HLSE:ORNBV
Orion Oyj
|
37.69 | 22.61% | 65.62% | 5,117.58 | 4.3% | -0.43% |
|
CPSE:HLUN A
H. Lundbeck A/S
|
37.40 | 76.03% | 100.03% | 36,603.66 | 1.87% | 31.06% |
|
CPSE:ALK B
ALK-Abelló A/S
|
152.00 | 48.16% | 94.21% | 33,908.31 | 0% | 171.44% |
|
NasdaqGS:ALKS
Alkermes
|
24.15 | 179.13% | 204.47% | 4,105.31 | 0% | 18.74% |
|
XTRA:MOR
MorphoSys
|
69.35 | 0% | 0% | 2,523.4 | 0% | 0% |
|
TWSE:1795
Lotus Pharmaceutical
|
301.00 | 30.46% | 46.03% | 74,712.3 | 1.55% | 106.37% |
|
BME:ALM
Almirall
|
9.27 | -45.22% | 27.15% | 1,944.22 | 2.05% | -30.96% |
